New Medicine by Design-funded research advances an under-skin cell therapy for type 1 diabetes
Research shows that transplanted pancreatic cells were able to survive in animal hosts.
Medicine by Design’s executive director launches new chapter in diabetes research with JDRF grant
$430,000 investment to study if a type of immune cell could be the key to transplanting insulin-producing cells for diabetes treatment
Medicine by Design Executive Director Michael Sefton elected to the U.S. National Academy of Engineering
U of T professor recognized for his accomplishments in tissue engineering
Innovation and science minister lauds Medicine by Design on regenerative medicine advances
'Your research will have a transformational impact on how we treat many common diseases, such as stroke, diabetes and liver failure, creating better health outcomes for all Canadians,' Bains tells annual symposium